Analysis of the clinical features in 204 cases of multiple sclerosis in Northeast China

Xin Zai-e,Guo Zhen-ni,Yang Y,Yang Yi

2012-01-01

Abstract:Objective To analysis the clinical features of multiple sclerosis(MS)in Northeast China.Methods We performed a retrospective clinical review include the manifestations,location of lesions,features of imaging,laboratory examination and treatment of 204 MS cases.Results(1)Of 204 cases(69 male and 135 female),95 cases(46.57%)aged from 20 to 40.(2)The onset of the disease was mostly acute or subacute(65.69%),and 25 cases(12.25%)had an inducement.(3)Paralysis(70.59%)was the most common nervous symptoms.56 cases(27.45%)had urinary or boweldy dysfunction.(4)The IgG of cerebrospinal fluid was increased in 62 cases(60.19%,n=103),43 cases had the visual and auditory evoked potential examination of brainstem and 69.77% were positive,34 cases had the somatosensory evoked potential examination and 2.94% were positive.5.73 cases(35.78%)with only brain lesions,followed by the spinal cords 53 cases(25.98%),and both brain and spinal cord involvement in 78 cases(38.24%).6.Family history of MS was not found in 204 cases.8 cases had autoimmune disease and 3 cases fell ill after postpartum.7.150 cases accepted treatment of hormone.The treatment effects were assessed using the expanded disability status scale(EDSS),and 78.67% were effective.Conclusion MS in Northeast China mainly invaded female who aged from 20 to 40 years.The clinical features of MS including that the onset age was later,the episode was more urgent,and elapsing-remitting MS accounted for most of the disease type.Most of cases had not inductive factors.The nervous symptoms were mainly dyskinesia and sensory disturbance.And the urinary or boweldy dysfunction was common.The MS lesions of brain were commonly involved subcortical white matter,the white matter around lateral ventricle,and semioval center,while cerebellum was seldom involved.The cervical spinal cords were easily involved.Steroid therapy has proved to be effective in the treatment of MS.